back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-11 14:04 Tx date 2023-12-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-412,776 vol |
2,951,212 | |
| Filed 2025-03-05 18:27 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,351,996
+443,973 vol $7.55 each |
3,807,961 | |
| Filed 2025-03-05 18:25 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-1,334,816
-166,852 vol $8.00 each |
457,581 | |
| Filed 2025-03-05 18:23 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+333,705 vol |
624,433 | |
| Filed 2025-03-05 18:21 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+290,728 vol |
290,728 | |
| Filed 2025-03-05 18:19 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-1,761,954.48
-222,469 vol $7.92 each |
663,495 | |
| Filed 2025-03-05 18:18 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-824,313.60
-104,080 vol $7.92 each |
885,964 | |
| Filed 2025-03-05 18:16 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-1,764,096
-220,512 vol $8.00 each |
990,044 | |
| Filed 2025-03-05 18:14 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+110,095 vol |
667,869 | |
| Filed 2025-03-05 18:12 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+51,507 vol |
557,774 | |
| Filed 2025-03-05 18:10 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+82,603 vol |
506,267 | |
| Filed 2025-03-05 18:09 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+109,168 vol |
423,664 | |
| Filed 2025-03-05 18:07 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+2,938 vol |
314,496 | |
| Filed 2024-03-08 11:25 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-1,245,826.40
-222,469 vol $5.60 each |
1,210,556 | |
| Filed 2024-03-08 11:10 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+144,781 vol |
311,558 | |
| Filed 2024-03-08 11:09 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+54,787 vol |
166,777 | |
| Filed 2024-03-08 11:07 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-1,245,826.40
-222,469 vol $5.60 each |
||
| Filed 2024-03-08 11:05 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-582,848
-104,080 vol $5.60 each |
1,433,025 | |
| Filed 2024-02-26 09:23 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+661,538 vol |
1,537,105 | |
| Filed 2024-02-26 09:21 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+4,886 vol |
111,990 | |
| Filed 2024-02-26 09:17 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+71,033 vol |
104,000 | |
| Filed 2024-02-26 09:11 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-913,822.40
-104,080 vol $8.78 each |
875,567 | |
| Filed 2023-03-07 10:32 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+71,330 vol |
||
| Filed 2023-03-07 10:31 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-930,475.20
-104,080 vol $8.94 each |
||
| Filed 2023-03-07 10:34 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+3,104 vol |
107,401 | |
| Filed 2023-03-07 10:32 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+71,330 vol |
104,297 | |
| Filed 2023-03-07 10:31 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-930,475.20
-104,080 vol $8.94 each |
875,567 | |
| Filed 2023-03-07 10:27 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+667,407 vol |
979,647 | |
| Filed 2022-03-07 17:08 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+19,232 vol |
32,967 | |
| Filed 2022-03-07 17:07 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-339,883
-28,300 vol $12.01 each |
0 | |
| Filed 2022-03-07 17:05 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
58 - Expiration of rights
|
-113,200 vol |
28,300 | |
| Filed 2022-03-07 15:37 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+312,240 vol |
312,240 | |
| Filed 2022-03-07 15:36 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-07 12:49 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+282 vol |
13,735 | |
| Filed 2022-03-07 11:32 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,415,597
+534,188 vol $12.01 each |
3,363,988 | |
| Filed 2021-05-12 17:23 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$54,888
+5,125 vol $10.71 each |
13,453 | |
| Filed 2020-12-23 18:30 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,645,822
+817,024 vol $13.03 each |
2,829,800 | |
| Filed 2020-10-26 15:13 Tx date 2020-10-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+141,500 vol |
141,500 | |
| Filed 2020-10-26 15:12 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-06 17:33 Tx date 2020-02-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,645,493
+412,776 vol $25.79 each |
2,012,776 | |
| Filed 2019-10-15 16:34 Tx date 2019-10-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,308
+8,328 vol $4.60 each |
8,328 | |
| Filed 2019-05-03 19:46 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$13,519,999
+1,600,000 vol $8.45 each |
1,600,000 | |
| Filed 2019-05-03 19:39 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-05-03 19:36 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|